Principal Financial Group
TNGX icon

Principal Financial Group’s Tango Therapeutics TNGX Stock Holding History

Principal Financial Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Buy
+10,769
New +$266K ﹤0.01% 2039
2024
Q3 		– Sell
-10,497
Closed -$90.1K – 2404
2024
Q2 		$90.1K Buy
+10,497
New +$81.1K ﹤0.01% 2229

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Principal Financial Group's TNGX Position: Q2 2026 in Review

Principal Financial Group opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 10,769 shares worth $337K. The stake represents ﹤0.01% of the portfolio and ranks #2039 among its holdings. This is a return to the name: Principal Financial Group previously reported a position in TNGX as recently as Q2 2024.

Principal Financial Group first reported a position in TNGX in Q2 2024 and has held it in 2 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Principal Financial Group held 10,769 shares of Tango Therapeutics worth $337K as of Q2 2026.
  • Tango Therapeutics was a new Principal Financial Group position in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2039 holding.
  • Principal Financial Group first reported a position in Tango Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.